Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
125.00    0.00 (0.00%)
Bid:
119.00
Ask:
124.50
Spread: 5.50 (4.622%)
Market Cap: £98.09m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Trading Update

12 Jan 2023 07:00

RNS Number : 4516M
Xaar PLC
12 January 2023
 

 

 

XAAR plc 

 

TRADING UPDATE

 

Xaar plc ("Xaar", "the Group" or "the Company"), the leading inkjet printing technology group, today announces a trading update for the year ended 31 December 2022.

 

TRADING

Strong revenue growth and full-year profitability

· Revenue for the period is expected to be approximately £74 million (2021: £59.3 million), representing year on year growth of 24% driven by a combination of organic growth (9%) and acquisitions

 

· The Group is expected to deliver an on track adjusted profit for the year

 

· During 2022 the Group continued to invest in working capital and infrastructure development and in March completed the acquisition of Megnajet

 

 

Further operational and strategic progress

· Further progress was made throughout the year in implementing the strategy to achieve long-term profitable growth

 

· Successful launch of Aqueous printhead product in November 2022 as planned, and on budget, is receiving strong customer engagement

 

· Factory reorganisation commenced in December and is progressing well and on schedule for completion by March 2023. This project is expected to deliver increased efficiency, reduce power usage, and reduce costs

 

· The integration of recent acquisitions (FFEI and Megnajet) has been completed successfully and both are contributing positively to Group results 

 

· Continued progress at EPS delivered its best performance to date with revenue growth of 36%

 

 

Challenging macro conditions expected to continue into 2023

· Sales volumes in the Printhead business continue to be affected by the uncertainty in China, which is expected to continue in the short term as Covid cases increase. At this stage it remains unclear when normal levels of business will return

 

· We have maintained our policy of increased investment in inventory to ensure availability of product during the factory reorganisation in Q1 2023 and the remainder of the year

 

BALANCE SHEET AND LIQUIDITY

· The Group remains well capitalised with a strong balance sheet with a net cash position as at 31 December 2022 of £8.6 million

 

 

John Mills, Chief Executive Officer, commented:

"I am hugely proud of the team in delivering a strong performance and making further progress with our strategy. We expect to deliver strong profitable revenue growth and the important milestone of achieving full year profitability representing great progress against our plan and remain well positioned for the business to achieve its exciting potential.

Aquinox has been successfully launched and is already being well received by our customers. With the operational improvements now well underway, notwithstanding the challenging external environment, the business is in good shape to continue to make further progress over the long term."

 

 

 

 

 

 

 

 

 

 

Enquiries:

 

Xaar plc

+44 (0) 1223 423 663 

Ian Tichias, Chief Financial Officer

John Mills, Chief Executive Officer

 

Tulchan Communications

Giles Kernick

Olivia Lucas

+44 (0) 207 353 4200

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSFIFWFEDSEDF
Date   Source Headline
1st Apr 20202:49 pmRNSTotal Voting Rights
1st Apr 20207:00 amRNSConfirmation of Board Changes and Succession
23rd Mar 20205:47 pmRNSTrading Statement-COVID-19 & Preliminary Statement
18th Mar 20204:42 pmRNSSecond Price Monitoring Extn
18th Mar 20204:36 pmRNSPrice Monitoring Extension
13th Mar 20208:41 amRNSHolding(s) in Company
2nd Mar 202011:38 amRNSTotal Voting Rights
25th Feb 20207:41 amRNSHolding(s) in Company
18th Feb 20201:04 pmRNSHolding(s) in Company
13th Feb 20204:57 pmRNSHolding(s) in Company
12th Feb 20205:25 pmRNSHolding(s) in Company
3rd Feb 202012:41 pmRNSTotal Voting Rights
16th Jan 20207:00 amRNSTrading Statement
9th Jan 20207:00 amRNSDirectorate Change
8th Jan 202011:09 amRNSHolding(s) in Company
3rd Jan 20203:32 pmRNSBlock listing Interim Review
2nd Jan 20202:15 pmRNSTotal Voting Rights
10th Dec 20193:51 pmRNSHolding(s) in Company
4th Dec 20194:53 pmRNSCompletion of Investment by Stratasys in Xaar 3D
2nd Dec 20195:39 pmRNSTotal Voting Rights
27th Nov 201910:35 amRNSResult of General Meeting
19th Nov 20199:23 amRNSHolding(s) in Company
18th Nov 20193:32 pmRNSHolding(s) in Company
8th Nov 20194:15 pmRNSPublication - Circular & Notice of General Meeting
1st Nov 201912:50 pmRNSTotal Voting Rights
23rd Oct 20198:30 amRNSHolding(s) in Company
23rd Oct 20198:30 amRNSHolding(s) in Company
11th Oct 20197:00 amRNSCEO Succession
8th Oct 20193:33 pmRNSHolding(s) in Company
8th Oct 20192:46 pmRNSHolding(s) in Company
7th Oct 201912:57 pmRNSGrant of Options
3rd Oct 20191:54 pmRNSHolding(s) in Company
1st Oct 20195:20 pmRNSTotal Voting Rights
1st Oct 20199:10 amRNSHolding(s) in Company
26th Sep 20197:00 amRNSBoard Changes and Succession
26th Sep 20197:00 amRNS2019 Interim Results
12th Sep 20197:00 amRNSProposed investment by Stratasys in Xaar 3D
3rd Sep 20197:00 amRNSTrading update & revised date for interim results
2nd Sep 201910:45 amRNSTotal Voting Rights
1st Aug 201910:39 amRNSTotal Voting Rights
31st Jul 201912:07 pmRNSSecond Price Monitoring Extn
31st Jul 201912:02 pmRNSPrice Monitoring Extension
26th Jul 20199:36 amRNSChange of Auditor
8th Jul 20197:00 amRNSScheduled Trading Statement
4th Jul 20195:30 pmRNSBLOCK LISTING SIX MONTHLY RETURN
1st Jul 20193:04 pmRNSTotal Voting Rights
5th Jun 20195:05 pmRNSTotal Voting Rights
28th May 201911:41 amRNSHolding(s) in Company
28th May 20199:08 amRNSHolding(s) in Company
21st May 20193:55 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.